Efficacy Outcomes of Fecal Microbiota, Live-jslm in Preventing Recurrent Clostridioides difficile Infection from Seven Clinical Studies.
Saved in:
| Title: | Efficacy Outcomes of Fecal Microbiota, Live-jslm in Preventing Recurrent Clostridioides difficile Infection from Seven Clinical Studies. |
|---|---|
| Authors: | Chopra T; Wayne State University, 4201 St Antoine, UHC-4G, Detroit, MI, 48201, USA. tchopra@med.wayne.edu., Van Handel D; MNGI Digestive Health, Minneapolis, MN, USA., Baggott B; Cleveland Clinic, Cleveland, OH, USA., Orenstein R; Mayo Clinic, Phoenix, AZ, USA.; Mayo Clinic Alix School of Medicine, Scottsdale, AZ, USA., Reveles K; The University of Texas at Austin, Austin, TX, USA., Guthmueller B; Ferring Pharmaceuticals, Inc, Parsippany, NJ, USA., Srivastava S; Ferring Pharmaceuticals A/S, Copenhagen, Denmark., Khanna S; Mayo Clinic, Rochester, MN, USA. |
| Source: | Infectious diseases and therapy [Infect Dis Ther] 2026 Aug; Vol. 15 (8), pp. 2071-2086. Date of Electronic Publication: 2026 Jun 12. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Adis Country of Publication: New Zealand NLM ID: 101634499 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2193-8229 (Print) Linking ISSN: 21936382 NLM ISO Abbreviation: Infect Dis Ther Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2193-8229 |
|---|---|
| DOI: | 10.1007/s40121-026-01374-9 |
